4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-026878
CEO sold 9,790 shares at $23.35 ($228,597)
- CEO acquired 91,725 shares (other)
- CEO acquired 17,662 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-14 | Exercise or conversion : show line 1 in the form | +7,979 | 636,451 | D | ||
| 2024-05-14 | Exercise or conversion : show line 2 in the form | +9,683 | 646,134 | D | ||
| 2022-02-14 | Other acquisition : show line 3 in the form | +23,940 | 670,074 | D | ||
| 2023-02-14 | Other acquisition : show line 4 in the form | +67,785 | 737,859 | D | ||
| 2024-05-16 | Sale : show line 5 in the form | −9,790 | $23.35 | $228,597 | 728,069 | D |
| Open-market sales · 9,790 sh · avg $23.35 · $228,597 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-14 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −7,979 | 23,940 | D |
| 2024-05-14 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −9,683 | 67,785 | D |
| 2022-02-14 | Other disposition : show line 8 in the form Restricted Stock Units | −23,940 | 0 | D |
| 2023-02-14 | Other disposition : show line 9 in the form Restricted Stock Units | −67,785 | 0 | D |
Loading xslF345X05/form4.xml…